PRESTIGE CONSUMER HEALTHCARE INC. Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price
PRESTIGE CONSUMER HEALTHCARE INC. (PBH) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price of $53.36 per share for the 12-month period ending 2026-03-31, per its 10-K filed 2026-05-14.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice · last filed 2026-08-06
- PRESTIGE CONSUMER HEALTHCARE INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2025-06-30 was $59.84, a 15.95% increase year-over-year.
- PRESTIGE CONSUMER HEALTHCARE INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2024-06-30 was $51.61, a 26.99% increase year-over-year.
- PRESTIGE CONSUMER HEALTHCARE INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2023-06-30 was $40.64, a 6.83% increase year-over-year.
- PRESTIGE CONSUMER HEALTHCARE INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2022-06-30 was $38.04, a 17.08% increase year-over-year.
- PRESTIGE CONSUMER HEALTHCARE INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2026 was $53.36, a 9.41% increase from fiscal 2025.
- PRESTIGE CONSUMER HEALTHCARE INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2025 was $48.77, a 18.72% increase from fiscal 2024.
- PRESTIGE CONSUMER HEALTHCARE INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2024 was $41.08, a 14.33% increase from fiscal 2023.
- PRESTIGE CONSUMER HEALTHCARE INC. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2023 was $35.93, a 15.35% increase from fiscal 2022.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 12 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 12 month as first filed |
|---|---|---|---|---|---|
| 2026-03-31 | $53.36 10-K · filed 2026-05-14 | ||||
| 2025-12-31 | $55.41 10-Q · filed 2026-02-05 | ||||
| 2025-09-30 | $55.41 10-Q · filed 2025-11-06 | ||||
| 2025-06-30 | $59.84 10-Q · filed 2026-08-06 | ||||
| 2025-03-31 | $48.77 10-K · filed 2026-05-14 | ||||
| 2024-12-31 | $50.59 10-Q · filed 2026-02-05 | ||||
| 2024-09-30 | $48.99 10-Q · filed 2025-11-06 | ||||
| 2024-06-30 | $51.61 10-Q · filed 2025-08-07 | ||||
| 2024-03-31 | $41.08 10-K · filed 2026-05-14 | ||||
| 2023-12-31 | $40.23 10-Q · filed 2025-02-06 | ||||
| 2023-09-30 | $39.85 10-Q · filed 2024-11-07 | ||||
| 2023-06-30 | $40.64 10-Q · filed 2024-08-08 | ||||
| 2023-03-31 | $35.93 10-K · filed 2025-05-09 | ||||
| 2022-12-31 | $35.82 10-Q · filed 2024-02-08 | ||||
| 2022-09-30 | $38.04 10-Q · filed 2023-11-02 | ||||
| 2022-06-30 | $38.04 10-Q · filed 2023-08-03 | ||||
| 2022-03-31 | $31.15 10-K · filed 2024-05-15 | ||||
| 2021-12-31 | $29.90 10-Q · filed 2023-02-02 | ||||
| 2021-09-30 | $30.91 10-Q · filed 2022-11-03 | ||||
| 2021-06-30 | $32.49 10-Q · filed 2022-08-04 | ||||
| 2021-03-31 | $23.83 10-K · filed 2023-05-05 | ||||
| 2020-12-31 | $20.14 10-Q · filed 2022-02-03 | ||||
| 2020-09-30 | $20.46 10-Q · filed 2021-11-04 | ||||
| 2020-06-30 | $20.10 10-Q · filed 2021-08-05 | ||||
| 2020-03-31 | $27.60 10-K · filed 2022-05-06 | ||||
| 2019-12-31 | $27.96 10-Q · filed 2021-02-04 | ||||
| 2019-09-30 | $29.57 10-Q · filed 2020-11-05 | ||||
| 2019-06-30 | $29.46 10-Q · filed 2020-08-06 | ||||
| 2019-03-31 | $30.02 10-K · filed 2021-05-07 | ||||
| 2018-12-31 | $30.02 10-Q · filed 2020-02-06 | ||||
| 2018-09-30 | $27.60 10-Q · filed 2019-10-31 | ||||
| 2018-06-30 | $26.81 10-Q · filed 2019-08-01 | ||||
| 2018-03-31 | $29.08 10-K · filed 2020-05-08 | ||||
| 2017-12-31 | $28.76 10-Q · filed 2019-02-07 | ||||
| 2017-09-30 | $28.76 10-Q · filed 2018-11-01 | ||||
| 2017-06-30 | $31.35 10-Q · filed 2018-08-02 | ||||
| 2017-03-31 | $31.75 10-K · filed 2019-05-13 | ||||
| 2016-12-31 | $31.91 10-Q · filed 2018-02-01 | ||||
| 2016-09-30 | $31.97 10-Q · filed 2017-11-02 | ||||
| 2016-06-30 | $32.20 10-Q · filed 2017-08-03 | ||||
| 2016-03-31 | $19.22 10-K · filed 2018-05-10 | ||||
| 2015-12-31 | $18.99 10-Q · filed 2017-02-02 | ||||
| 2015-09-30 | $18.99 10-Q · filed 2016-11-03 | ||||
| 2015-06-30 | $19.15 10-Q · filed 2016-08-04 | ||||
| 2015-03-31 | $10.24 10-K · filed 2017-05-17 | ||||
| 2014-12-31 | $10.05 10-Q · filed 2016-02-04 | ||||
| 2014-09-30 | $9.70 10-Q · filed 2015-11-05 | ||||
| 2014-06-30 | $13.80 10-Q · filed 2015-08-06 | ||||
| 2014-03-31 | $9.76 10-K · filed 2016-05-17 | ||||
| 2013-12-31 | $9.73 10-Q · filed 2015-02-05 | ||||
| 2013-09-30 | $9.54 10-Q · filed 2014-11-06 | ||||
| 2013-06-30 | $12.40 10-Q · filed 2014-08-07 | ||||
| 2013-03-31 | $7.67 10-K · filed 2015-05-14 | ||||
| 2012-12-31 | $7.71 10-Q · filed 2014-02-07 | ||||
| 2012-09-30 | $11.84 10-Q · filed 2013-11-07 | ||||
| 2012-06-30 | $11.84 10-Q · filed 2013-08-01 | ||||
| 2012-03-31 | $10.24 10-K · filed 2014-05-19 | $7.67 10-K · filed 2013-05-17 | |||
| 2011-12-31 | $10.54 10-Q · filed 2013-02-07 | ||||
| 2011-09-30 | $10.54 10-Q · filed 2012-11-07 | ||||
| 2011-06-30 | $10.57 10-Q · filed 2012-08-09 | ||||
| 2011-03-31 | $10.24 10-K · filed 2013-05-17 | ||||
| 2010-03-31 | $9.79 10-K · filed 2013-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 | |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |